NASDAQ:ACCD - Nasdaq - US00437E1029 - Common Stock - Currency: USD
ACCOLADE INC
NASDAQ:ACCD (2/10/2025, 8:00:00 PM)
Premarket: 6.87 -0.02 (-0.29%)6.89
+0.01 (+0.15%)
The current stock price of ACCD is 6.89 USD. In the past month the price increased by 0.88%. In the past year, price decreased by -44.26%.
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.71 | 81.45B | ||
CVS | CVS HEALTH CORP | 8.55 | 68.32B | ||
LH | LABCORP HOLDINGS INC | 16.82 | 20.50B | ||
DGX | QUEST DIAGNOSTICS INC | 18.31 | 18.44B | ||
DVA | DAVITA INC | 19.54 | 14.23B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.56 | 14.18B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 167.6 | 13.72B | ||
HIMS | HIMS & HERS HEALTH INC | 101.75 | 9.78B | ||
CHE | CHEMED CORP | 24.16 | 8.29B | ||
CRVL | CORVEL CORP | 28.08 | 6.03B | ||
GH | GUARDANT HEALTH INC | N/A | 5.49B | ||
OPCH | OPTION CARE HEALTH INC | 26.34 | 5.34B |
Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE INC
660 W. Germantown Pike Suite 500
Plymouth Meeting PENNSYLVANIA 98101 US
CEO: Rajeev Singh
Employees: 2400
Company Website: https://www.accolade.com
Investor Relations: https://ir.accolade.com/
Phone: 16108342989
The current stock price of ACCD is 6.89 USD.
The exchange symbol of ACCOLADE INC is ACCD and it is listed on the Nasdaq exchange.
ACCD stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ACCD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ACCD.
ACCD does not pay a dividend.
ACCD does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).
The outstanding short interest for ACCD is 4.27% of its float.
ChartMill assigns a technical rating of 9 / 10 to ACCD. When comparing the yearly performance of all stocks, ACCD is one of the better performing stocks in the market, outperforming 87.05% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to ACCD. The financial health of ACCD is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months ACCD reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS increased by 35.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -27.85% | ||
ROE | -57.6% | ||
Debt/Equity | 0.67 |
ChartMill assigns a Buy % Consensus number of 71% to ACCD. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of -0.47% and a revenue growth 12.44% for ACCD